Exploratory Biomarker Analyses of the Single-Arm, Phase 2 Study of Regorafenib Plus Nivolumab in Patients (pts) with Mismatch Repair-Proficient (pmmr)/microsatellite Stable (MSS) Colorectal Cancer (CRC)
JOURNAL OF CLINICAL ONCOLOGY(2022)
AI 理解论文
溯源树
样例

生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要